The influence of elevated liver function parameters on the pharmacokinetics of doxorubicin and epirubicin--a population based pharmacokinetic study of CESAR-APOH. Central European Society for Anticancer Drug Research. Working Group for Pharmacology in Oncology and Hematology.

International journal of clinical pharmacology and therapeutics

Volumn 40, Issue 12, 2002, Pages 575-577

  Muller H J ^a   Grubert, M ^a   Hilger, R ^a   Richly, H ^a   Port, R ^a   Scheulen, M ^a   Mross, K ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC ANTIBIOTIC; DOXORUBICIN; EPIRUBICIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; DOSE RESPONSE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LIVER; LIVER TUMOR; MALE; METABOLISM; METASTASIS; MIDDLE AGED; MULTICENTER STUDY; PROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBIOTICS, ANTINEOPLASTIC; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXORUBICIN; EPIRUBICIN; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 1842847329     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: 10.5414/CPP40575     Document Type: Article

References (0)